Showing results (101-110 of 282) with videos related to
Sort By:
Pageof 29
Frontiers in Nutrition|May 7, 2021
High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal SymptomsLauren A Killian, Jane G Muir, Jacqueline S Barrett, et al.Journal of Gastroenterology and Hepatology|October 5, 2012
Alternative investigations for irritable bowel syndromeHamish Philpott, Sanjay Nandurkar, John Lubel, et al.Journal of Gastroenterology and Hepatology|August 17, 2006
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approachDebbie M Nathan, Peter W Angus, Peter R GibsonJournal of Gastroenterology and Hepatology|June 15, 2007
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administrationDebbie M Nathan, John H Iser, Peter R GibsonAlimentary Pharmacology & Therapeutics|August 21, 2024
Review article: Evidence-based dietary management of inflammatory bowel diseasePeter R Gibson, C K Yao, Emma P HalmosJPEN. Journal of Parenteral and Enteral Nutrition|November 26, 2008
Strategies to manage gastrointestinal symptoms complicating enteral feedingJacqueline S Barrett, Susan J Shepherd, Peter R GibsonAlimentary Pharmacology & Therapeutics|March 5, 2020
Randomised clinical trial: transabdominal interferential electrical stimulation vs sham stimulation in women with functional constipationJudith S Moore, Peter R Gibson, Rebecca E BurgellWorld Journal of Gastroenterology|November 1, 2017
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?Abhinav Vasudevan, Peter R Gibson, Daniel R van LangenbergPlos One|January 15, 2019
Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seemsMary Ajamian, David Steer, Gennaro Rosella, et al.Inflammatory Bowel Diseases|January 29, 2019
Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel DiseaseAbhinav Vasudevan, Peter R Gibson, Daniel R Van LangenbergPageof 29